Stock Report

All about this stock under one free report Last Updated: 27-Aug-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Tonira Pharma [Merged] Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 530155

₹19.75

up-down-arrow ₹0.25 (1.28%)

As on 29-May-2012IST

Market cap

info icon

₹16 Cr

Revenue (TTM)

info icon

₹34 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

1.6

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 69.66 23.30 -8.38 -4.58 -1.38
EBIT 177.11 -56.18 -334.54 -262.08 -191.23
Net Profit 119.64 -55.42 -439.46 -204.77 -210.00
EPS 119.64 -55.42 -364.04 -44.53 -206.73
Book Value -- -- -14.51 -4.02 -7.70
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-11Mar-10
EBIT-Margin info 6.784.09-7.16-2.289.43
Net Margin info -1.87-3.75-9.63-6.542.72
Return on equity info -4.57-7.97-35.39-15.747.17
Return on Capital info 6.552.76--1.989.28
Return on Assets info -1.12-2.31-11.49-3.871.93
Debt to Equity (x) info ----3.993.022.20

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
--
1.97
9.86
7.83
-17.27
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-35.39

Lower than Peers by 46.25

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
-35.39
-15.65
7.48
-5.54
-34.82
Peer Median
10.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-11.49

Lower than Peers by 18.22

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
-11.49
-3.87
1.98
-1.47
-11.59
Peer Median
6.74
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-7.16

Lower than Peers by 19.85

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
-7.16
-2.28
9.42
13.21
-11.61
Peer Median
12.69
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-9.63

Lower than Peers by 18.49

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
-9.63
-6.54
2.72
-1.78
-17.57
Peer Median
8.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
--
3.26
10.43
4.93
-9.19
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-8.38

Lower than Peers by 16.52

Year on year growth in net sales

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
-8.38
-18.12
-10.70
26.78
-11.48
Peer Median
8.14
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-334.54

Lower than Peers by 351.78

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
-334.54
-119.84
-36.30
244.27
-187.92
Peer Median
17.24
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-439.46

Lower than Peers by 456.31

Year on year growth in profit after tax

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
-439.46
-303.24
237.56
87.23
-455.41
Peer Median
16.85
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-364.04

Lower than Peers by 374.64

Year on year growth in earnings per share

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
-364.04
-303.24
237.57
87.23
-455.41
Peer Median
10.60
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
--
-14.51
10.09
-6.06
-29.30
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

3.99

Higher than Peers by 3.95

Total debt / Net worth

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
3.99
3.00
2.18
2.07
2.08
Peer Median
0.04
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.97

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
0.97
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

3.44

Higher than Peers by 1.72

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
3.44
4.53
3.44
2.28
2.68
Peer Median
1.72
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

1.67

Higher than Peers by 0.49

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
1.67
2.18
1.98
1.14
1.15
Peer Median
1.17
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-0.15

Lower than Peers by 8.01

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
-0.15
0.30
1.47
0.90
-3.38
Peer Median
7.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

19.86

Lower than Peers by 5.93

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
19.86
12.63
17.18
18.09
16.66
Peer Median
25.79
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

1.15

Higher than Peers by 0.48

Sales / Average Total Assets

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
1.15
0.56
0.72
0.82
0.66
Peer Median
0.67
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
--
60.87
67.99
56.46
51.81
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
--
163.75
122.51
117.93
159.08
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
--
71.37
100.22
141.24
148.29
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
--
153.25
90.29
33.16
62.60
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
--
--
25.10
--
--
Peer Median
40.16
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

1.58

Lower than Peers by 2.58

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
1.58
1.21
1.79
0.86
1.56
Peer Median
4.16
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
--
--
--
--
--
Peer Median
0.11
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

33.96

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
33.96
12.32
7.64
4.31
-123.72
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

16

Lower than Peers by 7,579

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-11
Mar-10
Mar-09
Mar-08
Tonira Pharma [Merged]
16
15
26
11
22
Peer Median
7,594
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...